Peroxidasin-like protein: A novel peroxidase homologue in the human heart

Cardiovascular Research

Volumn 101, Issue 3, 2014, Pages 393-399

  Péterfi, Zalán ^a   Tóth, Zsuzsanna E ^a   Kovács, Hajnal A ^a   Lázár, Enik ^a   Sum, Adrienn ^a   Donkó, Ágnes ^a   Sirokmány, Gábor ^a   Shah, Ajay M ^b   Geiszt, Miklós ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Extracellular matrix; Peroxidase; Peroxidasin; Peroxidasin like protein; Reactive oxygen species

Indexed keywords

EXTRACELLULAR MATRIX; PEROXIDASE; PEROXIDASIN; PEROXIDASIN-LIKE PROTEIN; REACTIVE OXYGEN SPECIES;

ANIMALS; CELLS, CULTURED; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HEART; HEART FAILURE; HUMANS; IN SITU HYBRIDIZATION; OXIDATION-REDUCTION; PEROXIDASE; RNA, MESSENGER;

EID: 84894518087     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt256     Document Type: Article

References (16)

1. Berk BC, Fujiwara K, Lehoux S.ECMremodeling in hypertensive heart disease. J Clin Invest 2007;117:568-575.
2. Hutchinson KR, Stewart JA Jr, Lucchesi PA. Extracellular matrix remodeling during the progression of volume overload-induced heart failure. J Mol Cell Cardiol 2010;48: 564-569.
3. Donko A, Peterfi Z, Sum A, Leto T, GeisztM. Dual oxidases. Philos Trans R Soc Lond B Biol Sci 2005;360:2301-2308.
4. Nelson RE, Fessler LI, Takagi Y, Blumberg B, Keene DR, Olson PF et al. Peroxidasin: a novel enzyme-matrix protein of Drosophila development. EMBO J 1994;13: 3438-3447.
5. Soudi M, Zamocky M, Jakopitsch C, Furtmuller PG, Obinger C. Molecular evolution, structure, and function of peroxidasins. Chem Biodivers 2012;9:1776-1793.
6. Gotenstein JR, Swale RE, Fukuda T, Wu Z, Giurumescu CA, Goncharov A et al. The C. elegans peroxidasin PXN-2 is essential for embryonic morphogenesis and inhibits adult axon regeneration. Development 2010;137:3603-3613.
7. Peterfi Z, DonkoA, Orient A, SumA, Prokai A, Molnar Bet al. Peroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidney. Am J Pathol 2009;175:725-735.
8. Bhave G, Cummings CF, Vanacore RM, Kumagai-Cresse C, Ero-Tolliver IA, Rafi M et al. Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis. Nat Chem Biol 2012;8:784-790.
9. Cheng G, Salerno JC, Cao Z, Pagano PJ, Lambeth JD. Identification and characterization of VPO1, a new animal heme-containing peroxidase. Free Radic Biol Med 2008;45: 1682-1694.
10. Gu SQ, Bakthavachalu B, Han J, Patil DP, Otsuka Y, Guda C et al. Identification of the human PMR1 mRNA endonuclease as an alternatively processed product of the gene for peroxidasin-like protein. RNA 2012;18:1186-1196.
11. Konczol K, Bodnar I, Zelena D, Pinter O, Papp RS, Palkovits M et al. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic- pituitary-adrenal axis in rats. Neurochem Int 2010;57:189-197.
12. Furtmuller PG, Zederbauer M, JantschkoW, Helm J, Bogner M, JakopitschCet al. Active site structure and catalytic mechanisms of human peroxidases. Arch Biochem Biophys 2006;445:199-213.
13. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999;43:838-849.
14. Flesch M. On the trail of cardiac specific transcription factors. Cardiovasc Res 2001;50: 3-6.
15. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 2004;63:423-432.
16. Gaj T, Gersbach CA, Barbas CF III. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 2013;31:397-405.